ADVERSE DRUG EVENT
Clinical trials for ADVERSE DRUG EVENT explained in plain language.
Never miss a new study
Get alerted when new ADVERSE DRUG EVENT trials appear
Sign up with your email to follow new studies for ADVERSE DRUG EVENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Immune cells from your own tumor could fight cancer
Disease control CompletedThis early-stage study tested a treatment made from a patient's own tumor-fighting immune cells, called tumor-infiltrating lymphocytes (TILs). It included 43 adults with advanced solid tumors like melanoma, cervical cancer, and lung cancer. The goal was to find the safest dose an…
Matched conditions: ADVERSE DRUG EVENT
Phase: PHASE1 • Sponsor: Shanghai Juncell Therapeutics • Aim: Disease control
Last updated May 22, 2026 13:52 UTC
-
Immune cell attack: new hope for advanced melanoma patients
Disease control CompletedThis study tested a new treatment called GC101 TIL for people with advanced melanoma that did not respond to standard therapies. The treatment uses a patient's own immune cells, grown in a lab, to fight the cancer. The goal was to check safety and see if tumors shrink. 18 patient…
Matched conditions: ADVERSE DRUG EVENT
Phase: PHASE1, PHASE2 • Sponsor: Shanghai Juncell Therapeutics • Aim: Disease control
Last updated May 18, 2026 12:11 UTC
-
Massive study reviews NOCDURNA safety in over 1 million patients
Knowledge-focused CompletedThis study looked at medical records from Denmark, Sweden, and Germany to check the safety of NOCDURNA, a drug for frequent nighttime urination caused by nocturnal polyuria. Researchers tracked over 1 million adults to see how often serious side effects like low sodium levels occ…
Matched conditions: ADVERSE DRUG EVENT
Sponsor: Ferring Pharmaceuticals • Aim: Knowledge-focused
Last updated May 26, 2026 08:33 UTC
-
New tool aims to predict medication side effects before they send you back to the ER
Knowledge-focused CompletedThis study tested a risk prediction tool (ADE-RED) to identify emergency department patients at high risk for serious drug side effects that could lead to hospitalization. Researchers enrolled 471 adults and tracked whether the tool helped reduce return visits or hospital stays. …
Matched conditions: ADVERSE DRUG EVENT
Sponsor: Methodist Health System • Aim: Knowledge-focused
Last updated May 22, 2026 14:03 UTC